GLP-1 PatientCounseling Guides
Conversation frameworks, motivational interviewing scripts,and communication strategies for common GLP-1 therapy scenarios.
Opening the Conversation
“I'd like to talk with you about a medication option that has shown really strong results for people managing weight and metabolic health. Do you have a few minutes to discuss it?”
Setting Realistic Expectations
What to say about results:
“Most people start noticing reduced appetite in the first week. Measurable weight loss typically begins in weeks 2–4. The medication works best when paired with a higher-protein diet and staying active.”
What to say about side effects:
“About half of patients experience some nausea, especially in the first month. It usually improves significantly. We'll start at a low dose and increase gradually — and I have strategies to help if it's bothersome.”
Shared Decision-Making Framework
Managing Common Obstacles
“"It's completely normal to feel discouraged sometimes — this is a long-term process, not a quick fix. Let's look at what specifically is bothering you and adjust your plan together."”
Setting Realistic Expectations
What to say about plateaus:
“Plateaus are a normal part of the process, often happening around month 3-6. Your body is adjusting to its new set point. We can review your nutrition, activity, and dosing to help break through it.”
What to say about side effects:
“About half of patients experience some nausea, especially in the first month. It usually improves significantly. We'll start at a low dose and increase gradually — and I have strategies to help if it's bothersome.”
Problem-Solving Framework
Keeping Patients On Track
“"Life happens, and missing a dose here and there is common. Let's talk about what's making it hard to stay consistent, so we can find a routine that actually fits your life."”
Setting Realistic Expectations
What to say about missed doses
“Missing one dose occasionally won't undo your progress. If you miss more than a few days from your usual schedule, we may need to adjust your next dose — let's talk through the specific timing.”
What to say about motivation dips
“It's normal for motivation to fluctuate. Progress isn't always linear on the scale, but metabolic improvements are still happening even when the number doesn't move.”
Shared Decision-Making Framework
When Patients Consider Stopping
“Before we make a decision, let's talk through what stopping might mean for you — both the benefits and what to watch for, so you can make the choice that's right for you.”
Setting Realistic Expectations
What to say about weight regain risk
“Many people regain some weight after stopping, since GLP-1 therapy addresses biological appetite drivers that return once the medication is out of your system. A maintenance plan can help minimize this.”
What to say about tapering options
“Stopping doesn't have to be all-or-nothing. We can discuss a gradual dose reduction, alongside nutrition and activity strategies, to help you transition more smoothly.”
Shared Decision-Making Framework
Supplements designed for GLP-1 optimization
Clinically-informed supplements from STAAR LABS, formulated to support the metabolic goals of GLP-1 therapy.
View AllContribute to Our Knowledge Base
Share your clinical insights and help advance the standard of care for GLP-1 therapy
Submit Research or Case Study



